News | November 20, 2021
U.S. FDA allows Pfizer and Moderna booster doses for all
This is a shot in the arm for the vaccine manufacturers
This is a shot in the arm for the vaccine manufacturers
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
It is the first presbyopia-correcting lens implant for cataract surgery
The Pune centre expands its presence beyond Bangalore and Hyderabad
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices
Subscribe To Our Newsletter & Stay Updated
